Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
New identity emphasizes broad experience in classical small-molecule chemical development and contract synthesis.
October 16, 2023
By: Anthony Vecchione
Navin Fluorine International Ltd., part of the Padmanabh Mafatlal Group, unveiled the new identity for its contract development and manufacturing (CDMO) division, Navin Molecular. The new brand aims to meet the emerging need for reliable, fast, and cost-effective custom synthesis and manufacturing services for the pharmaceutical and speciality chemicals industries. In a statement, the company said that the new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. First, to allow customers to build a geographically diverse supply chain that operates to internationally recognized standards for quality, safety, and the environment. And second, to provide world-class facilities and strong expertise across the full range of complex chemistries that are required to manufacture advanced intermediates, including a range of extremely hazardous and challenging chemistries. The rebranding is a key part of a customer-focused initiative to realign Navin Molecular’s diverse expertise under three core offerings: custom synthesis, contract manufacturing, and process and analytical development. The new identity emphasizes its broad experience in classical small-molecule chemical development and contract synthesis. Rajendra Kumar Sahu, CEO of Navin Molecular said, “Since 2010 our CDMO division has been providing chemistry services which encompass a wide range of technologies. And, whilst direct fluorination and other hazardous chemistries remain core competencies, we’ve been working hard to integrate the full range of our expertise into the portfolio. The creation of the Navin Molecular brand is really the culmination of this work and, now that the rebrand is complete, we are very excited to share the details with our customers as we work towards being the partner of choice for the global pharmaceutical and speciality chemicals industry.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !